CRYSTAL PAWULA: Open Payments
NPI 1184092546 · NORTH VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 23 payments from 14 companies in 2025. Trend: 2023 $1,498 · 2024 $863 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $283 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $124 |
| Pulmonx Corporation | 1 | $110 |
| Boston Scientific Corporation | 1 | $93 |
| PFIZER INC. | 2 | $40 |
| Kite Pharma, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
Products named: REPATHA, BREZTRI, LifeVest, CHARTIS CATHETER, LATITUDE Communicator Power Supply, Yescarta, ELIQUIS, LEQVIO.
Industry payments across FL — which companies pay providers there.
